Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against Gram-negative bacteria

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2759-2765

  Le Roy, D ^a   Di Padova, F ^a   Adachi, Y ^a   Glauser, M P ^a   Calandra, T ^a   Heumann, D ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; IMMUNE RESPONSE; IMMUNITY; KLEBSIELLA PNEUMONIAE; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035451119     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2759     Document Type: Article

References (36)

1. Structure and function of lipopolysaccharide binding protein
2. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
3. Lipopolysaccharide-binding protein is required to combat a Gram-negative bacterial infection
4. Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock
5. Mode of action of anti-lipopolysaccharide binding protein (LBP) antibodies for prevention of endotoxemic shock in mice
6. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14
7. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice
8. Anti-CD14 mAb treatment provides therapeutic benefit after exposure to endotoxin
9. Antibodies against CD14 protect primates from endotoxin-induced shock
10. Blockade of CD14 increases Shigella-mediated invasion and tissue destruction
11. Choice of bacteria in animal models of sepsis
12. Cytokine signaling: Regulation of the immune response in normal and critically ill states
13. Evidence that tumor necrosis factor has an important role in antibacterial resistance
14. Anti-tumor necrosis factor antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudate and enhance the growth of Listeria monocytogenes in various organs
15. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
16. Multiple abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice
17. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
18. Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice
19. Role of tumor necrosis factor α in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa
20. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia
21. Tumor necrosis factor α receptor I is important for survival from Streptococcus pneumoniae infections
22. Protective effect of recombinant tumor necrosis factor-α in murine salmonellosis
23. Treatment with recombinant human tumor necrosis factor-α protects rats against the lethality, hypotension, and hypothermia of Gram-negative sepsis
24. Pretreatment with recombinant murine tumor necrosis factor α/cachectin and murine interleukin 1 α protects mice from lethal bacterial infection
25. Results of passive and active immunization directed against ferric aerobactin in experimental enterobacterial infections in mice and chickens
26. Cytokine production after intravenous or peritoneal Gram negative bacterial challenge in mice: Comparative protective efficacy of antibodies to TNFα and to LPS
27. Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages
28. Control of LPS binding and LPSinduced TNF secretion in human peripheral blood monocytes
29. Phagocytosis of Gram-negative bacteria by a unique CD14-dependent mechanism
30. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism
31. Reactivity of murine and human recombinant LPS-binding protein (LBP) with LPS and Gram negative bacteria
32. Reduced antilisterial activity of TNF-deficient bone marrow-derived macrophages is due to impaired superoxide production
33. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor
34. Effects of tumor necrosis factor on PMN chemotaxis, chemiluminescence, and elastase activity
35. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity
36. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein